Refine
Year of publication
Document Type
- Preprint (678)
- Article (608)
- Working Paper (5)
- Book (2)
- Review (1)
Has Fulltext
- yes (1294)
Is part of the Bibliography
- no (1294)
Keywords
- Heavy Ion Experiments (20)
- SARS-CoV-2 (12)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- prostate cancer (6)
- COVID-19 (5)
- COVID19-NMR (5)
- radical prostatectomy (5)
- ALICE experiment (4)
- Atmospheric chemistry (4)
- Collective Flow (4)
- Genetics (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Solution NMR spectroscopy (4)
- Solution NMR-spectroscopy (4)
- 5′-UTR (3)
- ALICE (3)
- Covid19-NMR (3)
- Heavy Ions (3)
- Immunology (3)
- Jets and Jet Substructure (3)
- Non-structural protein (3)
- Oncology (3)
- Pandemic (3)
- Seizure (3)
- chemotherapy (3)
- immunohistochemistry (3)
- pp collisions (3)
- systematic biopsy (3)
- ADHD (2)
- Beauty production (2)
- Bipolar disorder (2)
- Charm physics (2)
- Cochlear implant (2)
- Corona (2)
- Depression (2)
- Diagnosis (2)
- Digitalisierung (2)
- Digitization (2)
- EWSR1 (2)
- Epileptischer Anfall (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- FFLU (2)
- Fahrradmitnahme (2)
- Fahrradverleihsysteme (2)
- Gene fusion (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Liver transplantation (2)
- NMR spectroscopy (2)
- PD-L1 (2)
- PSA (2)
- Pandemie (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Protein drugability (2)
- Psychiatric disorders (2)
- QCD (2)
- RNA (2)
- SARS-CoV‑2 (2)
- Single electrons (2)
- Status epilepticus (2)
- Survival analysis (2)
- concordance (2)
- drug resistance (2)
- epidemiology (2)
- fMRI (2)
- fusion biopsy (2)
- immunotherapy (2)
- lung cancer (2)
- nutlin-3 (2)
- p53 (2)
- survival (2)
- targeted therapy (2)
- 19F (1)
- 3Cs technology (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 900 GeV (1)
- ABCB1 (1)
- ABCC1 (1)
- ACLF (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ASAP (1)
- Active middle ear implants (1)
- Acute HIV infection (1)
- Adults (1)
- Aedes aegypti (1)
- Agoraphobia (1)
- Amino acid analysis (1)
- Animal model (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Antifungal agents (1)
- Aortic valve replacement (1)
- Artificial Intelligence (1)
- Aspergillosis (1)
- Atmospheric science (1)
- Auditory system (1)
- Awareness campaign (1)
- Ayurveda (1)
- B cell malignancies (1)
- B cell receptor (1)
- BCOR (1)
- BCORL1 (1)
- BEACOPP (1)
- BI1361849 (1)
- BMI (1)
- BPH (1)
- BPO (1)
- BPTF (1)
- Behavior (1)
- Bike and Ride / Fahrrad-Abstellanlagen (1)
- Bilateral cochlear implant (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biogeochemistry (1)
- Biological heart valves (1)
- Biological markers (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Biophysical models (1)
- Bioprosthesis (1)
- Bone conduction devices (1)
- Bone tumor (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain (1)
- Brain tumor (1)
- Built environment (1)
- Business strategy in drug development (1)
- CD47 (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOUD experiment (1)
- COMT (1)
- COVID (1)
- CRPC (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CTLA-4 (1)
- CV9202 (1)
- Calcium signalling (1)
- Cancer (1)
- Cancer check up (1)
- Cancer genomics (1)
- Cancer treatment (1)
- Cardiac surgery (1)
- Carotid injury (1)
- Cell membranes (1)
- Centrality Class (1)
- Centrality Selection (1)
- Chemical composition (1)
- Chemokine CCL2 (1)
- Chemokines (1)
- Child abuse (1)
- Climate change (1)
- Climate-change impacts (1)
- Clinical Trials and Observations (1)
- Clinical genetics (1)
- Clinical practice guidelines (1)
- Clinical trial (1)
- Clinical variation (1)
- Collective Flow, (1)
- Combo® DTS (1)
- Compact city (1)
- Comparison with QCD (1)
- Complex decongestive therapy (1)
- Complication (1)
- Complications (1)
- Computed axial tomography (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Course (1)
- Course evaluation (1)
- Covid19-nmr (1)
- Crispr/Cas (1)
- Culex pipiens (1)
- Cycle streets (1)
- DNA sequence analysis (1)
- DNA-PAINT (1)
- DUBs (1)
- Decision Making und Risk (1)
- Demolition emissions (1)
- Design functions (1)
- Diagnostic markers (1)
- Dimerization domain (1)
- Direct reactions (1)
- Distance learning (1)
- Distanzunterricht (1)
- Doxorubicin (1)
- Drug screens (1)
- Drug therapy (1)
- D’Amico classification (1)
- EGFR (1)
- EP300 (1)
- Ecotoxicology (1)
- Elderly (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryos (1)
- Environment perception (1)
- Environmental Chemistry (1)
- Environmental impact (1)
- Epilepsy (1)
- Eurasian Curlew (1)
- Europe (1)
- Everolimus (1)
- Extended donor criteria (1)
- FBS (1)
- FGFR (1)
- FOXO1 (1)
- Fahrrad & ÖV (1)
- Fahrradabstellanalgen (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Financial Markets (1)
- Forschung (1)
- Frailty (1)
- Functional outcomes (1)
- GPS collar (1)
- Gene expression (1)
- Gene regulation (1)
- General practitioners (1)
- Gleason Score (1)
- Gleason score (1)
- Gleason upgrading (1)
- Global positioning system (1)
- Global warming (1)
- Graft function (1)
- Graft survival (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HBT (1)
- HIV (1)
- HNO (1)
- HOLEP (1)
- HSP (hereditary spastic paraplegia) (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Head bandage (1)
- Health care workers (1)
- Health policy (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hepatocellular carcinoma (1)
- Herbaria (1)
- HoLEP (1)
- Holmium laser enucleation (1)
- Hypertension (1)
- Hypofractionated radiotherapy (1)
- IAP (1)
- IFN (1)
- IHC (1)
- IPSS (1)
- Imaging genetics (1)
- Immune suppression (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- Incidental prostate cancer (1)
- Inclusive spectra (1)
- Inflammation (1)
- Insurance (1)
- Integrated urban planning (1)
- Integrierte Stadtentwicklung (1)
- Integrierte kommunale Strategien (1)
- Intensity interferometry (1)
- Intermodalität (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- KDIGO (1)
- KLHL11 (1)
- Kidney (1)
- Kompakte Stadt (1)
- Lafora disease (1)
- Lee type, functional outcome (1)
- Lehre (1)
- Lehrveranstaltungsevaluation (1)
- Leukemias (1)
- Library screening (1)
- Lipedema (1)
- Liposuction (1)
- Literature review (1)
- Liver diseases (1)
- Luciferase (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MDM2 (1)
- MN1 (1)
- MR-proADM (1)
- Machine learning (1)
- Macrodomain (1)
- Macrozoobenthos (1)
- Magnet dislocation (1)
- Magnetic resonance imaging (1)
- Marginal grafts (1)
- Marketing & Kommunikation (1)
- Material budget (1)
- Medical education (1)
- Medical history (1)
- Medizinstudium (1)
- Mental health and psychiatry (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methodenstudie (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mixed hearing loss (1)
- Mobility design (1)
- Mobilität (1)
- Mobilität in Deutschland (1)
- Mobilitätskennziffern (1)
- Mobilitätspanel (1)
- Molecular subtypes (1)
- Monte Carlo (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Mutation databases (1)
- Mycoses (1)
- Myeloid Neoplasia (1)
- N471D strumpellin knock-in mice (1)
- NADPH oxidase (1)
- NPSR1 (1)
- NURF (1)
- NVBP (1)
- Nachhaltige Stadtentwicklung (1)
- Nephrons (1)
- Neural network (1)
- Neuroepithelial (1)
- Neuroepithelial tumor (1)
- Neurooncology (1)
- Neuroscience (1)
- Nivolumab (1)
- Non-motorised travel (1)
- Non-small cell lung cancer (1)
- Non-small-cell lung cancer (1)
- Non–small-cell lung cancer (1)
- Nox4 (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleic acid-binding domain (1)
- Nucleocapsid (1)
- Nucleon induced nuclear reactions (1)
- Numenius arquata (1)
- OD approach (1)
- OR time (1)
- ORL (1)
- ORP (1)
- Observational study (1)
- Oldest-old (1)
- Online Survey (1)
- Organ rinse (1)
- Organ shortage (1)
- Otorhinolaryngological (1)
- Otorhinolaryngology (1)
- Outcome (1)
- Overall survival (1)
- Oxygen (1)
- PAD-test (1)
- PATZ1 (1)
- PCR (1)
- PCV (1)
- PD-1 (1)
- PLAGL1 (1)
- PM10 (1)
- PSA screening (1)
- PSA-Screening (1)
- PYTHIA (1)
- Panic disorder (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Pediatric (1)
- Personenmobilität (1)
- Phase 3 (1)
- Phosphorylation (1)
- Post-traumatic stress disorder (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Prognostic markers (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prostate cancer (1)
- Prostatic neoplasms (1)
- Protein druggability (1)
- Proton–proton (1)
- Prävention (1)
- Psychological and psychosocial issues (1)
- Psychology (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RARP (1)
- RITA (1)
- RNA genome (1)
- Rabbit (1)
- Radiation exposure (1)
- Radical nephrectomy (1)
- Radical prostatectomy (1)
- Radiofrequency ablation (1)
- Randomisation (1)
- Rapid diagnostic test (1)
- Rapidity Range (1)
- Raumstruktur (1)
- Reactive oxygen species (1)
- Real-world data (1)
- Region Rhein-Main (1)
- Registry (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Renal cancer (1)
- Renal system (1)
- Research (1)
- Research Infrastructure (1)
- Research funding (1)
- Residency (1)
- Resolution Parameter (1)
- Restenosis (1)
- Rhabdomyoma (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SAVI (1)
- SIRPalpha (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SMAD (1)
- SOFA (1)
- SPG8 (1)
- STING (1)
- Semantics (1)
- Sepsis (1)
- Septic shock (1)
- Sequential (1)
- Seroconverter (1)
- Shared space (1)
- Shell model (1)
- Simultaneous (1)
- Single muons (1)
- Single-cell RNA sequencing (1)
- Size distribution (1)
- Small molecules (1)
- Small-cell lung cancer (1)
- Specialist training (1)
- Spectroscopic factors & electromagnetic moments (1)
- Stadtplanung (1)
- Stechmückenfalle (1)
- Stegomyia aegypti (1)
- Streams (1)
- Street design (1)
- Structural protein (1)
- Supratentorial (1)
- Surgery (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- Sustainable urban development (1)
- Systematic Uncertainty (1)
- TGFβ (1)
- TR (1)
- TUR-P (1)
- Tacrolimus (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Temperature preference (1)
- Thermodynamics (1)
- Time Projection Chamber (1)
- Tools and ressources (1)
- Total operating room time (1)
- Tracking (1)
- Traditional Indian Medicine (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Transportation planning (1)
- Transurethral resection of the prostate (1)
- Transverse momentum (1)
- Travel behaviour (1)
- Treatment (1)
- Trigger (1)
- Tumor heterogeneity (1)
- Tumor therapy (1)
- Tumour biomarkers (1)
- Ultrafine particles (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper Rhine Valley (1)
- Urban aerosol (1)
- Urban planning (1)
- Urban space (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Ursus arctos (1)
- VX-2 (1)
- Vector Boson Production (1)
- Verkehr (1)
- Verkehrsplanung (1)
- Vesicles (1)
- Volmer–Weber growth (1)
- Vorsorgeuntersuchung (1)
- WASH complex subunit 5 (1)
- Weiterbildung (1)
- Westphal-Paradigm (1)
- X-ray powder diffraction (1)
- Xenon-based gas mixture (1)
- YM155 (1)
- accessory proteins (1)
- accident (1)
- activity sensors (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- adult (1)
- aerosol formation (1)
- aerosols (1)
- aggression (1)
- anti-EGFR therapy (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- antiviral therapy (1)
- arthritis (1)
- artifacts (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- atypical EGFR mutations (1)
- bicycle use (1)
- bioactivity testing (1)
- biogeographic legaciese (1)
- biomarker (1)
- biopsy (1)
- biopsy naïve (1)
- blood loss (1)
- brown bear (1)
- car use reduction (1)
- castration resistance (1)
- catheter removal (1)
- cell biology (1)
- cell lines (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemorefractory metastatic colorectal cancer (1)
- chemoresistance (1)
- cholangiocarcinoma (1)
- chronic total occlusion (1)
- cirrhosis (1)
- clinical practice (1)
- clinical trial (1)
- clinical trials (1)
- cluttering (1)
- complementary medicine (1)
- complexity (1)
- complications (1)
- consensus (1)
- coronavirus (1)
- correlation (1)
- cycle streets (1)
- cytotoxic T cells (1)
- dE/dx (1)
- data management (1)
- data quality (1)
- death rates (1)
- deferred treatment (1)
- delayed treatment (1)
- denisovite (1)
- detector (1)
- diffuse low-grade glioma (1)
- diffusion-weighted magnetic resonance imaging (1)
- digitale Vernetzung (1)
- disease prevalence (1)
- disorder (1)
- downgrading (1)
- early continence (1)
- easyPACId (1)
- ectosomes (1)
- electroencephalography (EEG) (1)
- electron crystallography (1)
- electron diffraction tomography (1)
- electronic diaries (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- epilepsy (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- fibrous materials (1)
- fluorine (1)
- forest classification (1)
- forest functional similarity (1)
- fragment screening (1)
- fragment-based screening (1)
- framework-structured solids (1)
- gRNA library (1)
- gene therapy (1)
- genetics (1)
- genetics and genomics (1)
- genome-wide (1)
- guidelines (1)
- haemophilia treatment (1)
- head-and-neck cancer (1)
- heavy ion experiments (1)
- histological outcomes (1)
- histopathological growth pattern (1)
- human (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- infection (1)
- injury (1)
- inorganic materials (1)
- integrative medicine (1)
- interaction effect (1)
- interim positron emissiontomography (1)
- interoperability (1)
- interstitial lung disease (1)
- intrinsically disordered region (1)
- inverse stage migration (1)
- irritable bowel syndrome (1)
- juvenile myoclonic epilepsy (1)
- layer-by-layer (LbL) (1)
- level-specific model fit (1)
- likelihood ratio test (1)
- liver (1)
- liver metastasis (1)
- liver transplantation (1)
- lockdown (1)
- loss-of-function (1)
- low-dose imaging (1)
- mRNA active cancer immunotherapy (1)
- mTOR (1)
- mTOR inhibitor (1)
- magnetic resonance imaging (1)
- maternal care (1)
- mechanical ventilation (1)
- medical risk factors (1)
- medulloblastoma (1)
- metal–organic frameworks (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microparticles (1)
- microsatellite instability (1)
- microvesicles (1)
- minerals (1)
- minimal information requirements (1)
- modularity (1)
- morbidity (1)
- mortality (1)
- mosquito trap (1)
- mpMRI (1)
- multicenter study (1)
- multilevel structural equation modeling (1)
- multiplexed immunofluorescence (1)
- multivariate mixed model (1)
- myositis (1)
- nanocrystalline materials (1)
- nanoparticle growth (1)
- nanoscience (1)
- nanostructure (1)
- natural products (1)
- neoadjuvant chemoradiotherapy (1)
- nerve-sparing (1)
- neuroblastoma (1)
- neurovascular bundle preservation (1)
- nitro-fatty acids (1)
- nodular lymphocyte-predominant Hodgkin lymphoma (1)
- non-small-cell lung cancer (1)
- nonstructural proteins (1)
- nutrition - clinical (1)
- optical coherence tomography (1)
- oral cavity cancer (1)
- organic thin films (1)
- p53 activator (1)
- palmitoylation (1)
- pediatric intensive care (1)
- penile cancer (1)
- peri-implantitis (1)
- perioperative outcome (1)
- personality (1)
- pharmacoresistance (1)
- phylogenetic community distance (1)
- polytypism (1)
- predictive biomarker (1)
- prognosis (1)
- progressive myoclonus epilepsy (1)
- prostate neoplasm (1)
- prostate volume (1)
- prostate-specific antigen (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- pseudomonas aeruginosa (1)
- pulmonary failure (1)
- quark gluon plasma (1)
- radiation (1)
- radical prostatecomy (1)
- radiotherapy (1)
- randomized (1)
- re-exposure (1)
- reactive oxygen species (1)
- rechallenge (1)
- reintroduction (1)
- repeat biopsy (1)
- repeatability (1)
- reproducibility (1)
- resilience (1)
- respiratory failure (1)
- rigor (1)
- risk factors (1)
- risk stratification (1)
- robust test statistic (1)
- satellite telemetry (1)
- schizophrenia (1)
- secondary data analysis (1)
- selenolates (1)
- self-assembled monolayers (1)
- sepsis (1)
- simplified production (1)
- single subject classification (1)
- smart home (1)
- smart living (1)
- spectra (1)
- stage-based models (1)
- standardization (1)
- structural proteins (1)
- strumpellin (1)
- stuttering (1)
- subgrouping (1)
- surface chemistry (1)
- surface-mounted metal–organic frameworks (SURMOFs) (1)
- surgical margin (1)
- survivin (1)
- sustainable travel (1)
- targeted biopsy (1)
- temozolomide (1)
- temporal classification (1)
- thiolates (1)
- transrectal prostate biopsy (1)
- trauma (1)
- travel behavior change (1)
- treatment centres (1)
- treatment resistance (1)
- triptycene (1)
- tropical forests (1)
- tumor microenvironment (1)
- tumor weight (1)
- tyrosine kinase inhibitor (TKI) (1)
- upgrading (1)
- uveal melanoma (1)
- ventral striatum (1)
- volatile organic compounds (1)
- waiting time (1)
- web of things (1)
- Öffentlichkeit (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1060)
- Frankfurt Institute for Advanced Studies (FIAS) (955)
- Informatik (923)
- Medizin (123)
- Geowissenschaften (42)
- Biowissenschaften (13)
- Biochemie, Chemie und Pharmazie (11)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (8)
- Geographie (7)
- Geowissenschaften / Geographie (7)
Measurement of ϒ(1S) elliptic flow at forward rapidity in Pb–Pb collisions at √sNN = 5.02 TeV
(2019)
The first measurement of the Υ(1S) elliptic flow coefficient (v2) is performed at forward rapidity (2.5 < y < 4) in Pb-Pb collisions at sNN−−−√=5.02 TeV with the ALICE detector at the LHC. The results are obtained with the scalar product method and are reported as a function of transverse momentum (pT) up to 15 GeV/c in the 5-60% centrality interval. The measured Υ(1S) v2 is consistent with zero and with the small positive values predicted by transport models within uncertainties. The v2 coefficient in 2 < pT < 15 GeV/c is lower than that of inclusive J/ψ mesons in the same pT interval by 2.6 standard deviations. These results, combined with earlier suppression measurements, are in agreement with a scenario in which the Υ(1S) production in Pb-Pb collisions at LHC energies is dominated by dissociation limited to the early stage of the collision whereas in the J/ψ case there is substantial experimental evidence of an additional regeneration component.
Measurement of ϒ(1S) elliptic flow at forward rapidity in Pb–Pb collisions at √sNN = 5.02 TeV
(2019)
The first measurement of the Υ(1S) elliptic flow coefficient (v2) is performed at forward rapidity (2.5 < y < 4) in Pb-Pb collisions at sNN−−−√=5.02 TeV with the ALICE detector at the LHC. The results are obtained with the scalar product method and are reported as a function of transverse momentum (pT) up to 15 GeV/c in the 5-60% centrality interval. The measured Υ(1S) v2 is consistent with zero and with the small positive values predicted by transport models within uncertainties. The v2 coefficient in 2 < pT < 15 GeV/c is lower than that of inclusive J/ψ mesons in the same pT interval by 2.6 standard deviations. These results, combined with earlier suppression measurements, are in agreement with a scenario in which the Υ(1S) production in Pb-Pb collisions at LHC energies is dominated by dissociation limited to the early stage of the collision whereas in the J/ψ case there is substantial experimental evidence of an additional regeneration component.
Measurement of ϒ(1S) elliptic flow at forward rapidity in Pb–Pb collisions at √sNN = 5.02 TeV
(2019)
The first measurement of the Υ(1S) elliptic flow coefficient (v2) is performed at forward rapidity (2.5 < y < 4) in Pb-Pb collisions at sNN−−−√=5.02 TeV with the ALICE detector at the LHC. The results are obtained with the scalar product method and are reported as a function of transverse momentum (pT) up to 15 GeV/c in the 5-60% centrality interval. The measured Υ(1S) v2 is consistent with zero and with the small positive values predicted by transport models within uncertainties. The v2 coefficient in 2 < pT < 15 GeV/c is lower than that of inclusive J/ψ mesons in the same pT interval by 2.6 standard deviations. These results, combined with earlier suppression measurements, are in agreement with a scenario in which the Υ(1S) production in Pb-Pb collisions at LHC energies is dominated by dissociation limited to the early stage of the collision whereas in the J/ψ case there is substantial experimental evidence of an additional regeneration component.
An improved value for the lifetime of the (anti-)hypertriton has been obtained using the data sample of Pb-Pb collisions at sNN−−−√= 5.02 TeV collected by the ALICE experiment at the LHC. The (anti-)hypertriton has been reconstructed via its charged two-body mesonic decay channel and the lifetime has been determined from an exponential fit to the dN/d(ct) spectrum. The measured value, τ = 242+34−38 (stat.) ± 17 (syst.) ps, is compatible with all the available theoretical predictions, thus contributing to the solution of the longstanding hypertriton lifetime puzzle.
An improved value for the lifetime of the (anti-)hypertriton has been obtained using the data sample of Pb-Pb collisions at sNN−−−√= 5.02 TeV collected by the ALICE experiment at the LHC. The (anti-)hypertriton has been reconstructed via its charged two-body mesonic decay channel and the lifetime has been determined from an exponential fit to the dN/d(ct) spectrum. The measured value, τ = 242+34−38 (stat.) ± 17 (syst.) ps, is compatible with all the available theoretical predictions, thus contributing to the solution of the longstanding hypertriton lifetime puzzle.
The production rates and the transverse momentum distribution of strange hadrons at mid-rapidity ( |y |<0.5) are measured in proton-proton collisions at s√ = 13 TeV as a function of the charged particle multiplicity, using the ALICE detector at the LHC. The production rates of K0S, Λ, Ξ, and Ω increase with the multiplicity faster than what is reported for inclusive charged particles. The increase is found to be more pronounced for hadrons with a larger strangeness content. Possible auto-correlations between the charged particles and the strange hadrons are evaluated by measuring the event-activity with charged particle multiplicity estimators covering different pseudorapidity regions. When comparing to lower energy results, the yields of strange hadrons are found to depend only on the mid-rapidity charged particle multiplicity. Several features of the data are reproduced qualitatively by general purpose QCD Monte Carlo models that take into account the effect of densely-packed QCD strings in high multiplicity collisions. However, none of the tested models reproduce the data quantitatively. This work corroborates and extends the ALICE findings on strangeness production in proton-proton collisions at 7 TeV.
The first measurement at the LHC of charge-dependent directed flow (v1) relative to the spectator plane is presented for Pb-Pb collisions at sNN−−−√ = 5.02 TeV. Results are reported for charged hadrons and D0 mesons for the transverse momentum intervals pT>0.2 GeV/c and 3<pT< 6 GeV/c in the 5-40% and 10-40% centrality classes, respectively. The difference between the positively and negatively charged hadron v1 is found to have a positive slope as a function of pseudorapidity η, dΔv1/dη=[1.68 ± 0.49 (stat.) ± 0.41 (syst.)] ×10−4, with a 2.6σ significance. The same measurement for D0 and D¯0 mesons yields a positive value dΔv1/dη= [4.9 ± 1.7 (stat.) ± 0.6 (syst.)]×10−1, which is about three orders of magnitude larger than the one of the charged hadrons, and is larger than zero with significance of 2.7σ. These measurements can provide new insights into the effects of the strong electromagnetic field and the initial tilt of matter created in non-central heavy-ion collisions on the dynamics of light (u, d, and s) and heavy (c) quarks. The large difference between the observed Δv1 of charged hadrons and D0 mesons may reflect different sensitivity of the charm and light quarks to the early time dynamics of a heavy-ion collision. These observations challenge some of the recent theoretical calculations incorporating effects of the strong electromagnetic field, which predicted a negative and an order of magnitude smaller value of dΔv1/dη for both light-flavour and charmed hadrons.
Υ production in p-Pb interactions is studied at the centre-of-mass energy per nucleon-nucleon collision sNN−−−√ = 8.16 TeV with the ALICE detector at the CERN LHC. The measurement is performed reconstructing bottomonium resonances via their dimuon decay channel, in the centre-of-mass rapidity intervals 2.03<ycms<3.53 and −4.46<ycms<−2.96, down to zero transverse momentum. In this work, results on the inclusive Υ(1S) production cross section as a function of rapidity and transverse momentum are presented. The corresponding nuclear modification factor shows a suppression of the Υ(1S) yields with respect to pp collisions, both at forward and backward rapidity. This suppression is stronger in the low transverse momentum region and shows no significant dependence on the centrality of the interactions. Furthermore, the Υ(2S) nuclear modification factor is also evaluated, suggesting a suppression similar to that of the Υ(1S). A first measurement of the Υ(3S) has also been performed. Finally, results are compared with previous measurements performed by ALICE in p-Pb collisions at sNN−−−√ = 5.02 TeV and with theoretical calculations.
Υ production in p-Pb interactions is studied at the centre-of-mass energy per nucleon-nucleon collision sNN−−−√ = 8.16 TeV with the ALICE detector at the CERN LHC. The measurement is performed reconstructing bottomonium resonances via their dimuon decay channel, in the centre-of-mass rapidity intervals 2.03<ycms<3.53 and −4.46<ycms<−2.96, down to zero transverse momentum. In this work, results on the inclusive Υ(1S) production cross section as a function of rapidity and transverse momentum are presented. The corresponding nuclear modification factor shows a suppression of the Υ(1S) yields with respect to pp collisions, both at forward and backward rapidity. This suppression is stronger in the low transverse momentum region and shows no significant dependence on the centrality of the interactions. Furthermore, the Υ(2S) nuclear modification factor is also evaluated, suggesting a suppression similar to that of the Υ(1S). A first measurement of the Υ(3S) has also been performed. Finally, results are compared with previous measurements performed by ALICE in p-Pb collisions at sNN−−−√ = 5.02 TeV and with theoretical calculations.
Inclusive Υ production in p-Pb interactions is studied at the centre-of-mass energy per nucleon-nucleon collision sNN−−−√ = 8.16 TeV with the ALICE detector at the CERN LHC. The measurement is performed reconstructing bottomonium resonances via their dimuon decay channel, in the centre-of-mass rapidity intervals 2.03<ycms<3.53 and −4.46<ycms<−2.96, down to zero transverse momentum. In this work, results on the inclusive Υ(1S) production cross section as a function of rapidity and transverse momentum are presented. The corresponding nuclear modification factor shows a suppression of the Υ(1S) yields with respect to pp collisions, both at forward and backward rapidity. This suppression is stronger in the low transverse momentum region and shows no significant dependence on the centrality of the interactions. The inclusive Υ(2S) nuclear modification factor is also evaluated, suggesting a suppression similar to that of the Υ(1S). Finally, results are compared with previous measurements performed by ALICE in p-Pb collisions at sNN−−−√ = 5.02 TeV and with theoretical calculations.
Measurements of identified hadrons as a function of the charged-particle multiplicity in pp collisions enable a search for the onset of collective effects in small collision systems. With such measurements, it is possible to study the mechanisms that determine the shapes of hadron transverse momentum (pT) spectra, to search for possible modifications of the yields of short-lived hadronic resonances due to scattering effects in the hadron-gas phase, and to investigate different explanations for the multiplicity evolution of strangeness production provided by phenomenological models. In this paper, these topics are addressed through measurements of the K∗(892)0 and ϕ(1020) mesons at midrapidity in pp collisions at s√ = 13 TeV as a function of the charged-particle multiplicity. The results include the pT spectra, pT-integrated yields, mean transverse momenta, and the ratios of the yields of these resonances to those of longer-lived hadrons. Comparisons with results from other collision systems and energies, as well as predictions from phenomenological models, are also discussed.
The jet radial structure and particle transverse momentum (pT) composition within jets are presented in centrality-selected Pb-Pb collisions at sNN−−−√ = 2.76 TeV. Track-based jets, which are also called charged jets, were reconstructed with a resolution parameter of R=0.3 at midrapidity |ηchjet|<0.6 for transverse momenta pT,chjet=30-120 GeV/c. Jet-hadron correlations in relative azimuth and pseudorapidity space (Δφ, Δη) are measured to study the distribution of the associated particles around the jet axis for different pT,assoc-ranges between 1 and 20 GeV/c. The data in Pb-Pb collisions are compared to reference distributions for pp collisions, obtained using embedded PYTHIA simulations. The number of high-pT associate particles (4<pT,assoc<20 GeV/c) in Pb-Pb collisions is found to be suppressed compared to the reference by 30 to 10%, depending on centrality. The radial particle distribution relative to the jet axis shows a moderate modification in Pb-Pb collisions with respect to PYTHIA. High-pT associate particles are slightly more collimated in Pb-Pb collisions compared to the reference, while low-pT associate particle tend to be broadened. The results, which are presented for the first time down to pT,chjet=30 GeV/c in Pb-Pb collisions, are compatible with both previous jet-hadron-related measurements from the CMS Collaboration and jet shape measurements from the ALICE Collaboration at higher pT, and add further support for the established picture of in-medium parton energy loss.
The jet radial structure and particle transverse momentum (pT) composition within jets are presented in centrality-selected Pb−Pb collisions at sNN−−−√ = 2.76 TeV. Track-based jets, which are also called charged jets, were reconstructed with a resolution parameter of R=0.3 at midrapidity |ηchjet|<0.6 for transverse momenta pT,chjet=30-120 GeV/c. Jet−hadron correlations in relative azimuth and pseudorapidity space (Δφ, Δη) are measured to study the distribution of the associated particles around the jet axis for different pT,assoc-ranges between 1 and 20 GeV/c. The data in Pb−Pb collisions are compared to reference distributions for pp collisions, obtained using embedded PYTHIA simulations. The number of high-pT associate particles (4<pT,assoc<20 GeV/c) in Pb−Pb collisions is found to be suppressed compared to the reference by 30 to 10\%, depending on centrality. The radial particle distribution relative to the jet axis shows a moderate modification in Pb−Pb collisions with respect to PYTHIA. High-pT associate particles are slightly more collimated in Pb−Pb collisions compared to the reference, while low-pT associate particle tend to be broadened. The results, which are compatible with both previous jet−hadron-related measurements from the CMS Collaboration and jet shape measurements from the ALICE Collaboration at higher pT, support the currently established picture of in-medium parton energy loss.
Measurement of the production of charm jets tagged with D0 mesons in pp collisions at √s = 7 TeV
(2019)
The production of charm jets in proton-proton collisions at a center-of-mass energy of s√=7 TeV was measured with the ALICE detector at the CERN Large Hadron Collider. The measurement is based on a data sample corresponding to a total integrated luminosity of 6.23 nb−1, collected using a minimum-bias trigger. Charm jets are identified by the presence of a D0 meson among their constituents. The D0 mesons are reconstructed from their hadronic decay D0→K−π+. The D0-meson tagged jets are reconstructed using tracks of charged particles (track-based jets) with the anti-kT algorithm in the jet transverse momentum range 5<pchT,jet<30 GeV/c and pseudorapidity |ηjet|<0.5. The fraction of charged jets containing a D0-meson increases with pchT,jet from 0.042±0.004(stat)±0.006(syst) to 0.080±0.009(stat)±0.008(syst). The distribution of D0-meson tagged jets as a function of the jet momentum fraction carried by the D0 meson in the direction of the jet axis (zch||) is reported for two ranges of jet transverse momenta, 5<pchT,jet<15 GeV/c and 15<pchT,jet<30 GeV/c in the intervals 0.2<zch||<1.0 and 0.4<zch||<1.0, respectively. The data are compared with results from Monte Carlo event generators (PYTHIA 6, PYTHIA 8 and Herwig 7) and with a Next-to-Leading-Order perturbative Quantum Chromodynamics calculation, obtained with the POWHEG method and interfaced with PYTHIA 6 for the generation of the parton shower, fragmentation, hadronisation and underlying event.
Measurement of the production of charm jets tagged with D0 mesons in pp collisions at √s = 7 TeV
(2019)
The production of charm jets in proton-proton collisions at a center-of-mass energy of s√=7 TeV was measured with the ALICE detector at the CERN Large Hadron Collider. The measurement is based on a data sample corresponding to a total integrated luminosity of 6.23 nb−1, collected using a minimum-bias trigger. Charm jets are identified by the presence of a D0 meson among their constituents. The D0 mesons are reconstructed from their hadronic decay D0→K−π+. The D0-meson tagged jets are reconstructed using tracks of charged particles (track-based jets) with the anti-kT algorithm in the jet transverse momentum range 5<pchT,jet<30 GeV/c and pseudorapidity |ηjet|<0.5. The fraction of charged jets containing a D0-meson increases with pchT,jet from 0.042±0.004(stat)±0.006(syst) to 0.080±0.009(stat)±0.008(syst). The distribution of D0-meson tagged jets as a function of the jet momentum fraction carried by the D0 meson in the direction of the jet axis (zch||) is reported for two ranges of jet transverse momenta, 5<pchT,jet<15 GeV/c and 15<pchT,jet<30 GeV/c in the intervals 0.2<zch||<1.0 and 0.4<zch||<1.0, respectively. The data are compared with results from Monte Carlo event generators (PYTHIA 6, PYTHIA 8 and Herwig 7) and with a Next-to-Leading-Order perturbative Quantum Chromodynamics calculation, obtained with the POWHEG method and interfaced with PYTHIA 6 for the generation of the parton shower, fragmentation, hadronisation and underlying event.
Study of the Λ–Λ interaction with femtoscopy correlations in pp and p–Pb collisions at the LHC
(2019)
This work presents new constraints on the existence and the binding energy of a possible Λ-Λ bound state, the H-dibaryon, derived from Λ-Λ femtoscopic measurements by the ALICE collaboration. The results are obtained from a new measurement using the femtoscopy technique in pp collisions at s√=13 TeV and p-Pb collisions at sNN−−−√=5.02 TeV, combined with previously published results from p-Pb collisions at s√=7 TeV. The Λ-Λ scattering parameter space, spanned by the inverse scattering length f−10 and the effective range d0, is constrained by comparing the measured Λ-Λ correlation function with calculations obtained within the Lednicky model. The data are compatible with hypernuclei results and lattice computations, both predicting a shallow attractive interaction, and permit to test different theoretical approaches describing the Λ-Λ interaction. The region in the (f−10,d0) plane which would accommodate a Λ-Λ bound state is substantially restricted compared to previous studies. The binding energy of the possible Λ-Λ bound state is estimated within an effective-range expansion approach and is found to be BΛΛ=3.2+1.6−2.4(stat)+1.8−1.0(syst) MeV.
Study of the Λ–Λ interaction with femtoscopy correlations in pp and p–Pb collisions at the LHC
(2019)
This work presents new constraints on the existence and the binding energy of a possible Λ-Λ bound state, the H-dibaryon, derived from Λ-Λ femtoscopic measurements by the ALICE collaboration. The results are obtained from a new measurement using the femtoscopy technique in pp collisions at s√=13 TeV and p-Pb collisions at sNN−−−√=5.02 TeV, combined with previously published results from p-Pb collisions at s√=7 TeV. The Λ-Λ scattering parameter space, spanned by the inverse scattering length f−10 and the effective range d0, is constrained by comparing the measured Λ-Λ correlation function with calculations obtained within the Lednicky model. The data are compatible with hypernuclei results and lattice computations, both predicting a shallow attractive interaction, and permit to test different theoretical approaches describing the Λ-Λ interaction. The region in the (f−10,d0) plane which would accommodate a Λ-Λ bound state is substantially restricted compared to previous studies. The binding energy of the possible Λ-Λ bound state is estimated within an effective-range expansion approach and is found to be BΛΛ=3.2+1.6−2.4(stat)+1.8−1.0(syst) MeV.
Inclusive J/ψ production is studied in minimum-bias proton-proton collisions at a centre-of-mass energy of s√ = 5.02 TeV by ALICE at the CERN LHC. The measurement is performed at mid-rapidity (|y|<0.9) in the dielectron decay channel down to zero transverse momentum pT, using a data sample corresponding to an integrated luminosity of Lint=19.4± 0.4 nb−1. The measured pT-integrated inclusive J/ψ production cross section is dσ/dy = 5.64 ± 0.22 (stat.) ±0.33 (syst.) ±0.12 (lumi.) μb. The pT-differential cross section d2σ/dpTdy is measured in the pT range 0−10 GeV/c and compared with state-of-the-art QCD calculations. The J/ψ ⟨pT⟩ and ⟨p2T⟩ are extracted and compared with results obtained at other collision energies.
Inclusive J/ψ production is studied in minimum-bias proton-proton collisions at a centre-of-mass energy of s√ = 5.02 TeV by ALICE at the CERN LHC. The measurement is performed at mid-rapidity (|y|<0.9) in the dielectron decay channel down to zero transverse momentum pT, using a data sample corresponding to an integrated luminosity of Lint=19.4± 0.4 nb−1. The measured pT-integrated inclusive J/ψ production cross section is dσ/dy = 5.64 ± 0.22 (stat.) ±0.33 (syst.) ±0.12 (lumi.) μb. The pT-differential cross section d2σ/dpTdy is measured in the pT range 0−10 GeV/c and compared with state-of-the-art perturbative QCD calculations. The J/ψ ⟨pT⟩ and ⟨p2T⟩ are extracted and compared with results obtained at other collision energies.